These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

175 related items for PubMed ID: 2591447

  • 1. Experiences with SCC antigen, a new tumor marker for cervical carcinoma.
    Meier W, Eiermann W, Stieber P, Schneider A, Fateh-Moghadam A, Hepp H.
    Eur J Cancer Clin Oncol; 1989 Nov; 25(11):1555-9. PubMed ID: 2591447
    [Abstract] [Full Text] [Related]

  • 2. [Experiences with the squamous cell carcinoma antigen, a new tumor marker for cancer of the uterine cervix].
    Meier W, Eiermann W, Stieber P, Fateh-Moghadam A, Hepp H.
    Geburtshilfe Frauenheilkd; 1989 Jul; 49(7):625-9. PubMed ID: 2777050
    [Abstract] [Full Text] [Related]

  • 3. [Determination of the SCC antigen in the serum of patients with cervical cancer].
    Crombach G, Würz H, Bolte A.
    Geburtshilfe Frauenheilkd; 1987 Jul; 47(7):439-45. PubMed ID: 3623046
    [Abstract] [Full Text] [Related]

  • 4. [SCC (squamous cell carcinoma) antigen as a tumor marker in cervix cancers].
    Geyer H, Schwörer D, Pfleiderer A.
    Geburtshilfe Frauenheilkd; 1989 Mar; 49(3):266-71. PubMed ID: 2721888
    [Abstract] [Full Text] [Related]

  • 5. Squamous cell carcinoma antigen in cervical cancer.
    Borras G, Molina R, Xercavins J, Ballesta A, Iglesias X.
    Eur J Gynaecol Oncol; 1992 Mar; 13(5):414-8. PubMed ID: 1486921
    [Abstract] [Full Text] [Related]

  • 6. The clinical value of squamous cell carcinoma antigen in cancer of the uterine cervix.
    de Bruijn HW, Duk JM, van der Zee AG, Pras E, Willemse PH, Boonstra H, Hollema H, Mourits MJ, de Vries EG, Aalders JG.
    Tumour Biol; 1998 Mar; 19(6):505-16. PubMed ID: 9817980
    [Abstract] [Full Text] [Related]

  • 7. Squamous cell carcinoma antigen, tumor-associated trypsin inhibitor, and carcinoembryonic antigen for monitoring cervical cancer.
    Pectasides D, Economides N, Bourazanis J, Pozadzizou P, Gogou L, Koutsiouba P, Athanassiou A.
    Am J Clin Oncol; 1994 Aug; 17(4):307-12. PubMed ID: 8048392
    [Abstract] [Full Text] [Related]

  • 8. Serum levels of squamous cell carcinoma antigen and ovarian carcinoma antigen (CA 125) in patients with benign and malignant diseases of the uterine cervix.
    Gocze PM, Vahrson HW, Freeman DA.
    Oncology; 1994 Aug; 51(5):430-4. PubMed ID: 8052484
    [Abstract] [Full Text] [Related]

  • 9. [Usefulness of the SCC, CEA, CYFRA 21.1, and CRP markers for the diagnosis and monitoring of cervical squamous cell carcinoma].
    Chmura A, Wojcieszek A, Mrochem J, Walaszek-Gruszka A, Deja R, Masłyk B, Bartnik W, Sodowski K.
    Ginekol Pol; 2009 May; 80(5):361-6. PubMed ID: 19548456
    [Abstract] [Full Text] [Related]

  • 10. Evaluation of carcinoembryonic antigen, tissue polypeptide antigen, and squamous cell carcinoma antigen in the detection of cervical cancers.
    Lam CP, Yuan CC, Jeng FS, Tsai LC, Yeh SH, Ng HT.
    Zhonghua Yi Xue Za Zhi (Taipei); 1992 Jul; 50(1):7-13. PubMed ID: 1326391
    [Abstract] [Full Text] [Related]

  • 11. Clinical significance of squamous cell carcinoma antigen in cancer of the human uterine cervix. Comparison with CEA and CA-125.
    Verlooy H, Devos P, Janssens J, Mortelmans L, Gerits M, Bonte J, De Roo M.
    Gynecol Obstet Invest; 1991 Jul; 32(1):55-8. PubMed ID: 1765320
    [Abstract] [Full Text] [Related]

  • 12. Clinical value of routine serum squamous cell carcinoma antigen in follow-up of patients with early-stage cervical cancer.
    Esajas MD, Duk JM, de Bruijn HW, Aalders JG, Willemse PH, Sluiter W, Pras B, ten Hoor K, Hollema H, van der Zee AG.
    J Clin Oncol; 2001 Oct 01; 19(19):3960-6. PubMed ID: 11579117
    [Abstract] [Full Text] [Related]

  • 13. [Significance and implication on changes of serum squamous cell carcinoma antigen in the diagnosis of recurrence squamous cell carcinoma of cervix].
    Li Q, Liu S, Liu H, Zhang J, Guo S, Wang L.
    Zhonghua Fu Chan Ke Za Zhi; 2015 Feb 01; 50(2):131-6. PubMed ID: 25877611
    [Abstract] [Full Text] [Related]

  • 14. Clinical value of tumor markers for early detection of recurrence in patients with cervical adenocarcinoma and adenosquamous carcinoma.
    Tabata T, Takeshima N, Tanaka N, Hirai Y, Hasumi K.
    Tumour Biol; 2000 Feb 01; 21(6):375-80. PubMed ID: 11006578
    [Abstract] [Full Text] [Related]

  • 15. Serum squamous cell carcinoma antigen in gynecologic malignancies with special reference to cervical cancer.
    Hsieh CY, Chang DY, Huang SC, Yen ML, Juang GT, Ouyang PC.
    Taiwan Yi Xue Hui Za Zhi; 1989 Aug 01; 88(8):797-800. PubMed ID: 2592943
    [Abstract] [Full Text] [Related]

  • 16. Prognostic significance of pretreatment serum levels of squamous cell carcinoma antigen and CA 125 in cervical carcinoma.
    Avall-Lundqvist EH, Sjövall K, Nilsson BR, Eneroth PH.
    Eur J Cancer; 1992 Aug 01; 28A(10):1695-702. PubMed ID: 1389488
    [Abstract] [Full Text] [Related]

  • 17. Cervical carcinoma: a comparison of four potential biochemical tumor markers.
    Dodd JK, Henry RJ, Tyler JP, Houghton CR.
    Gynecol Oncol; 1989 Feb 01; 32(2):248-52. PubMed ID: 2910788
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Serum squamous cell carcinoma antigen levels in invasive cervical cancer: prediction of response and recurrence.
    Rose PG, Baker S, Fournier L, Nelson BE, Hunter RE.
    Am J Obstet Gynecol; 1993 Mar 01; 168(3 Pt 1):942-6. PubMed ID: 8456907
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.